Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab LtdfiledCriticalRanbaxy Lab Ltd
Publication of AR036360A1publicationCriticalpatent/AR036360A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Reivindicación 1: Un proceso para la preparación de un sistema de administración de una vez al día para administración por vía oral en seres humanos referido a la liberación controlada de droga que comprende una cantidad farmacéuticamente efectiva de droga en combinación con una matriz polimérica caracterizada en que por lo menos uno de los polímeros es polímero carboxivinilo y que constituye por lo menos 30% de peso del contenido polimérico total y un éter de celulosa, un compuesto alcalino y opcionalmente, otros componentes auxiliares farmacéuticamente aceptables. Reivindicación 3: Un proceso conforme a la reivindicación 1 en donde la droga es ofloxacina o sus sales farmacéuticamente aceptables.Claim 1: A process for the preparation of a once-daily administration system for oral administration in humans referred to the controlled release of drug comprising a pharmaceutically effective amount of drug in combination with a polymer matrix characterized in that At least one of the polymers is carboxyvinyl polymer and it constitutes at least 30% by weight of the total polymer content and a cellulose ether, an alkaline compound and optionally, other pharmaceutically acceptable auxiliary components. Claim 3: A process according to claim 1 wherein the drug is ofloxacin or its pharmaceutically acceptable salts.
ARP020103201A2001-08-242002-08-26
PROCESS FOR THE PREPARATION OF A DRUG ADMINISTRATION SYSTEM ONCE A DAY BY ORAL ROUTE
AR036360A1
(en)
Spontaneously dispersible pharmaceutical composition for oral administration comprising n-benzoyl-staurosporine; method to increase levels of bioavailability. (divisional of only 333-00).
PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
VITRONECTIN RECEPTOR ANTAGONISTS, A METHOD FOR THEIR PREPARATION, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
PHARMACEUTICAL FORMULATION OF PROLONGED RELEASE, IMPROVED FOR THE ORAL ADMINISTRATION OF NEFAZODONA OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME; ORAL DOSAGE FORM THAT UNDERSTANDS AND USE OF SUCH FORMULATION TO PREPARE THE SUCH DOSAGE FORM